Bazedoxifene/conjugated estrogens, sold under the brand name Duavee among others, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[3][4][5] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens.[3] It is taken by mouth.[3]
The combination was approved for medical use in the United States in October 2013,[6] and in the European Union in December 2014.[7]